Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

599 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of stigmatizing views towards COVID-19 and mental disorders among adolescent and young adult students in China.
Zhang TM, Zhang XF, Meng XD, Huang Y, Zhang W, Gong HH, Chan SKW, Chen XC, Gao R, Lewis-Fernández R, Fan YY, Liu CC, Huang L, Deng XP, Liu B, Ran MS. Zhang TM, et al. Among authors: chen xc. Front Psychiatry. 2023 Jul 6;14:1170540. doi: 10.3389/fpsyt.2023.1170540. eCollection 2023. Front Psychiatry. 2023. PMID: 37484667 Free PMC article.
The mutual overlapping impact of stress and infection on mental health problems in adolescents and youths during and after COVID-19 pandemic in China.
Ran MS, Wang C, Cai J, Deng ZY, Mu YF, Huang Y, Zhang W, Song HJ, Deng AP, Qiu CJ, Shen WW, Chen Y, Zhang L, Meng XD, Huang XH, Chen T, Meng YJ, Chen J, Liu T, Li B, Long J, Liu B, Gao R, Chen XC, Liu GL. Ran MS, et al. Among authors: chen j, chen t, chen y, chen xc. J Affect Disord. 2024 Feb 15;347:500-508. doi: 10.1016/j.jad.2023.12.009. Epub 2023 Dec 7. J Affect Disord. 2024. PMID: 38065477
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial.
Chen XC, Jiao DC, Qiao JH, Wang CZ, Sun XF, Lu ZD, Li LF, Zhang CJ, Yan M, Wei Y, Chen B, Feng YQ, Deng M, Ma MD, Plichta JK, He YW, Liu ZZ. Chen XC, et al. Lancet Oncol. 2025 Jan;26(1):27-36. doi: 10.1016/S1470-2045(24)00581-3. Epub 2024 Nov 26. Lancet Oncol. 2025. PMID: 39612919 Clinical Trial.
A large-scale population-based study reveals that gp42-IgG antibody is protective against Epstein-Barr virus-associated nasopharyngeal carcinoma.
Kong XW, Bu GL, Chen H, Huang YH, Liu Z, Kang YF, Li YC, Yu X, Wu BH, Li ZQ, Chen XC, Xie SH, Lin DF, Li T, Yan SM, Han RK, Huang N, Wang QY, Li Y, Zhang A, Zhong Q, Huang XM, Ye W, Ji MF, Cai YL, Cao SM, Zeng MS. Kong XW, et al. Among authors: chen xc. J Clin Invest. 2024 Nov 26:e180216. doi: 10.1172/JCI180216. Online ahead of print. J Clin Invest. 2024. PMID: 39589824 Free article.
599 results